0

Global Pancreatic Cancer Therapeutics Market 2019-2023

  • Published: Dec 2018
  • Pages: 123
  • SKU: IRTNTR30555
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The global pancreatic cancer therapeutics market size will grow by USD 1.11 billion during 2019-2023. This industry research report provides a detailed analysis of the market based on products (targeted therapy and chemotherapy), type (exocrine pancreatic cancer, and endocrine pancreatic cancer), and geography (the Americas, APAC, and EMEA). The report analyzes the market’s competitive landscape and offers information on several pancreatic cancer therapeutics manufacturers including Eli Lilly, F. Hoffmann-La Roche, Novartis, Pfizer, and Shire.

Below are some of the key findings from this pancreatic cancer therapeutics market analysis report

pancreatic cancer therapeutics

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global pancreatic cancer therapeutics industry outlook

The rising prevalence of pancreatic cancer in developed countries due to the lack of therapeutic approaches for early-stage detection is driving the pancreatic cancer therapeutics market. The high incidence of pancreatic cancer leads to germline mutations which cause the defective genes to pass from parents to children, making the early detection of pancreatic cancer important, leading to the growth of the pancreatic cancer therapeutics market.

The increasing demand for targeted therapy is another factor driving the growth of the pancreatic cancer therapeutics market. Targeted therapy singles out specific receptors that are present in the cancer cells and does not harm the peripheral healthy cells of the body unlike the traditional therapeutics method like chemotherapy. The rising prevalence of pancreatic cancer coupled with increasing demand for targeted therapy is driving the pancreatic cancer therapeutics market growth at a CAGR of more than 8% during the forecast period.

Top pancreatic cancer therapeutics companies covered in this market research report

The global pancreatic cancer therapeutics market is extremely concentrated. The market is in the growth phase, and the competition is expected to become intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this pancreatic cancer therapeutics market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.

The report offers a detailed analysis of several leading companies, including:

  • Eli Lilly
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Shire

Pancreatic cancer therapeutics market segmentation based on products

  • Targeted therapy
  • Chemotherapy

Targeted therapy was dominating the global pancreatic cancer therapeutics market in 2018. The market share of this segment will increase, and it will continue to dominate the market throughout the next five years.

Pancreatic cancer therapeutics market segmentation based on region

  • The Americas
  • APAC
  • EMEA

The Americas accounted for the largest pancreatic cancer therapeutics market share in 2018. This region will witness an increase in its market share and remain the market leader for the next five years.

Key highlights of the global pancreatic cancer therapeutics market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the pancreatic cancer therapeutics market during the next five years
  • Precise estimation of the global pancreatic cancer therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the pancreatic cancer therapeutics industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of pancreatic cancer therapeutics companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Targeted therapy - Market size and forecast 2018-2023
  • Chemotherapy - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

  • Exocrine pancreatic cancer
  • Endocrine pancreatic cancer

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Eli Lilly
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Shire

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>